VEGFA and colorectal carcinoma: No associations of VEGF polymorphisms with responsiveness to chemotherapy were found in the subgroup including anti-angiogenic agent, indicating that SNPs in the VEGF gene might have weak ability to predict the responsiveness to chemotherapy of CRC patients receiving anti-angiogenic agents, alone or in combination with other first-line chemotherapy regimens.